Class information for:
Level 1: CODISPENSING//RISK EVALUATION AND MITIGATION STRATEGIES//BOXED WARNINGS

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
28567 204 25.0 60%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
1 4 ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL 3876184
320 3       AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//MEDICATION ERRORS//AMERICAN JOURNAL OF HOSPITAL PHARMACY 39312
2978 2             PHARMACOVIGILANCE//ADVERSE DRUG REACTIONS//DRUG SAFETY 2605
28567 1                   CODISPENSING//RISK EVALUATION AND MITIGATION STRATEGIES//BOXED WARNINGS 204

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 CODISPENSING authKW 336786 1% 75% 3
2 RISK EVALUATION AND MITIGATION STRATEGIES authKW 311835 2% 42% 5
3 BOXED WARNINGS authKW 299367 1% 100% 2
4 DEAR DOCTOR authKW 299367 1% 100% 2
5 DEAR DOCTOR LETTERS authKW 299367 1% 100% 2
6 DRUG LABEL CHANGE authKW 299367 1% 100% 2
7 DRUG SAFETY OVERSIGHT BOARD address 299367 1% 100% 2
8 LABORATORY MONITORING authKW 233146 4% 17% 9
9 ADVERSE DRUG EVENTS QT INTERVAL authKW 149683 0% 100% 1
10 BLANCHE IRWIN LERNER STUDY PHARMACEUT MANAG address 149683 0% 100% 1

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Pharmacology & Pharmacy 1693 53% 0% 108
2 Health Care Sciences & Services 1500 19% 0% 38
3 Public, Environmental & Occupational Health 917 28% 0% 57
4 Health Policy & Services 695 10% 0% 20
5 Medical Informatics 610 7% 0% 14
6 Medicine, General & Internal 229 17% 0% 34
7 Toxicology 191 10% 0% 20
8 Medical Laboratory Technology 101 4% 0% 8
9 Information Science & Library Science 24 2% 0% 4
10 Primary Health Care 16 1% 0% 2

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 DRUG SAFETY OVERSIGHT BOARD 299367 1% 100% 2
2 BLANCHE IRWIN LERNER STUDY PHARMACEUT MANAG 149683 0% 100% 1
3 CLIN PHARMACOLPHARMACOEPIDEMIOL PROGRAM 149683 0% 100% 1
4 DIS DECIS SUPPORT GRP 149683 0% 100% 1
5 DRUG SAFETY I3 149683 0% 100% 1
6 ECREENING TEST EVALUAT PROGRAM 149683 0% 100% 1
7 EPIDEMIOL DRUG SAFETY SURVEILLANCE 149683 0% 100% 1
8 FALLON FDN FALLON COMMUNITY HLTH PLAN 149683 0% 100% 1
9 FARM GRANADA 149683 0% 100% 1
10 INTERDISCIPLINARY WOMENS HLTHSEALY A 149683 0% 100% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 47266 13% 1% 27
2 HOSPITAL PHARMACY 21382 0% 14% 1
3 DRUG SAFETY 20734 8% 1% 17
4 THERAPEUTIC INNOVATION & REGULATORY SCIENCE 10299 2% 1% 5
5 JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION 2916 2% 0% 4
6 AMERICAN JOURNAL OF MANAGED CARE 2688 3% 0% 7
7 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 2020 3% 0% 7
8 POPULATION HEALTH MANAGEMENT 1456 1% 0% 2
9 DRUG INFORMATION JOURNAL 1222 1% 0% 3
10 RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY 1186 1% 0% 2

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 CODISPENSING 336786 1% 75% 3 Search CODISPENSING Search CODISPENSING
2 RISK EVALUATION AND MITIGATION STRATEGIES 311835 2% 42% 5 Search RISK+EVALUATION+AND+MITIGATION+STRATEGIES Search RISK+EVALUATION+AND+MITIGATION+STRATEGIES
3 BOXED WARNINGS 299367 1% 100% 2 Search BOXED+WARNINGS Search BOXED+WARNINGS
4 DEAR DOCTOR 299367 1% 100% 2 Search DEAR+DOCTOR Search DEAR+DOCTOR
5 DEAR DOCTOR LETTERS 299367 1% 100% 2 Search DEAR+DOCTOR+LETTERS Search DEAR+DOCTOR+LETTERS
6 DRUG LABEL CHANGE 299367 1% 100% 2 Search DRUG+LABEL+CHANGE Search DRUG+LABEL+CHANGE
7 LABORATORY MONITORING 233146 4% 17% 9 Search LABORATORY+MONITORING Search LABORATORY+MONITORING
8 ADVERSE DRUG EVENTS QT INTERVAL 149683 0% 100% 1 Search ADVERSE+DRUG+EVENTS+QT+INTERVAL Search ADVERSE+DRUG+EVENTS+QT+INTERVAL
9 CANCER RISK WITH BECAPLERMIN 149683 0% 100% 1 Search CANCER+RISK+WITH+BECAPLERMIN Search CANCER+RISK+WITH+BECAPLERMIN
10 CLINICAL PHARMACIST TEAMS 149683 0% 100% 1 Search CLINICAL+PHARMACIST+TEAMS Search CLINICAL+PHARMACIST+TEAMS

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 MCDOWELLL, SE , FERNER, RE , (2011) BIOCHEMICAL MONITORING OF PATIENTS TREATED WITH ANTIHYPERTENSIVE THERAPY FOR ADVERSE DRUG REACTIONS A SYSTEMATIC REVIEW.DRUG SAFETY. VOL. 34. ISSUE 11. P. 1049-1059 19 51% 4
2 SANFELIX-GIMENO, G , CERVERA-CASINO, P , PEIRO, S , LOPEZ-VALCARCEL, BG , BLAZQUEZ, A , BARBERA, T , (2009) EFFECTIVENESS OF SAFETY WARNINGS IN ATYPICAL ANTIPSYCHOTIC DRUGS AN INTERRUPTED TIME-SERIES ANALYSIS IN SPAIN.DRUG SAFETY. VOL. 32. ISSUE 11. P. 1075 -1087 17 55% 11
3 MACIEJEWSKI, ML , HAMMILL, BG , QUALLS, LG , HASTINGS, SN , WANG, V , CURTIS, LH , (2016) APPROPRIATE BASELINE LABORATORY TESTING FOLLOWING ACEI OR ARB INITIATION BY MEDICARE FFS BENEFICIARIES.PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. VOL. 25. ISSUE 9. P. 1015 -1022 13 57% 0
4 CHENG, CM , DELIZZA, C , KAPUSNIK-UNER, J , (2014) PREVALENCE AND THERAPEUTIC CLASSIFICATIONS OF FDA-APPROVED PRESCRIPTION DRUGS WITH BOXED WARNINGS.THERAPEUTIC INNOVATION & REGULATORY SCIENCE. VOL. 48. ISSUE 2. P. 165-172 6 100% 1
5 THEOPHILE, H , MIREMONT-SALAME, G , ROBINSON, P , MOORE, N , BEGAUD, B , HARAMBURU, F , (2011) RELEVANCE OF A "DEAR DOCTOR LETTER" TO ALERT HEALTHCARE PROVIDERS TO NEW RECOMMENDATIONS FOR VITAMIN D ADMINISTRATION.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 67. ISSUE 7. P. 681-686 11 58% 2
6 HOFFMAN, KB , DEMAKAS, AR , DIMBIL, M , TATONETTI, NP , ERDMAN, CB , (2014) STIMULATED REPORTING: THE IMPACT OF US FOOD AND DRUG ADMINISTRATION-ISSUED ALERTS ON THE ADVERSE EVENT REPORTING SYSTEM (FAERS).DRUG SAFETY. VOL. 37. ISSUE 11. P. 971 -980 18 32% 5
7 RODRIGUEZ-MONGUIO, R , SPIELBERGER, K , SEOANE-VAZQUEZ, E , (2014) EXAMINATION OF RISK EVALUATION AND MITIGATION STRATEGIES AND DRUG SAFETY IN THE US.RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY. VOL. 10. ISSUE 1. P. 232-238 7 78% 1
8 WINTERFIELD, L , VLEUGELS, RA , PARK, KK , (2015) THE VALUE OF THE BLACK BOX WARNING IN DERMATOLOGY.JOURNAL OF DRUGS IN DERMATOLOGY. VOL. 14. ISSUE 7. P. 12 -18 10 50% 0
9 MURTAZA, G , KHAN, SA , MURTAZA, G , JAVED, K , AKRAM, F , HAMID, AA , HUSSAIN, I , (2014) AN ASSESSMENT OF PAKISTANI PHARMACY AND MEDICAL STUDENTS' KNOWLEDGE OF BLACK BOX WARNINGS.ACTA BIOETHICA. VOL. 20. ISSUE 1. P. 119 -124 7 70% 0
10 GOLDMAN, RE , SORAN, CS , HAYWARD, GL , SIMON, SR , (2010) DOCTORS' PERCEPTIONS OF LABORATORY MONITORING IN OFFICE PRACTICE.JOURNAL OF EVALUATION IN CLINICAL PRACTICE. VOL. 16. ISSUE 6. P. 1136 -1141 10 53% 7

Classes with closest relation at Level 1



Rank Class id link
1 17931 ACTIVATION SYNDROME//FORENS TOXICOL FORENS GENET//N WALES PSYCHOL MED
2 4114 PHARMACOVIGILANCE//ADVERSE DRUG REACTIONS//DRUG SAFETY
3 17257 POTENTIAL DRUG DRUG INTERACTIONS//DRUG DRUG INTERACTIONS//DRUG INTERACTIONS
4 21681 NEPHROLOGY CLINICAL PRACTICE GUIDELINES//SERUM MEDIATORS//BILATERAL URETER LIGATED RATS
5 11919 SERTINDOLE//TORSADES DE POINTES//TORSADE DE POINTES
6 18020 DIRECT TO CONSUMER ADVERTISING//DTCA//DIRECT TO CONSUMER ADVERTISING DTCA
7 16184 ORPHAN DRUGS//RARE DISEASES//ORPHAN DRUG ACT
8 26445 DRUG LAG//JAPANESE CLINICAL TRIALS//GLOBAL DRUG DEVELOPMENT
9 16303 FOOD AND DRUG LAW JOURNAL//MEDICAL DEVICE INNOVATION//DEVICE APPROVAL
10 553 ELECTRONIC HEALTH RECORDS//INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS//JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

Go to start page